# Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules

> **NCT06279533** · PHASE1 · COMPLETED · sponsor: **Vigonvita Life Sciences** · enrollment: 49 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** LV232/Placebo
- **DRUG:** LV232

## Key facts

- **NCT ID:** NCT06279533
- **Lead sponsor:** Vigonvita Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-27
- **Primary completion:** 2024-12-17
- **Final completion:** 2024-12-17
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06279533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06279533, "Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06279533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*